Digital Therapeutics (DTx) Market Size by Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation and Others), By End-use (Patients, Providers, Payers, Employers and Others), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2023-2028
The Digital Therapeutics (DTx) Market is expected to be around US$ 18 Billion by 2028 at a CAGR of 31% in the given forecast period.
COVID-19 Impact Analysis Report
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
31
REPORT DESCRIPTION
The Digital Therapeutics (DTx) Market is expected to be around US$ 18 Billion by 2028 at a CAGR of 31% in the given forecast period.
The fueling sales of smart devices such as mobile phones and tablets, growing internet penetration and the rising number of healthcare applications are among the key factors empowering the growth of the market. Digital therapeutics finds application in a wide range of neuroscience indications, such as autism spectrum disorder (ASD), depression, schizophrenia, attention deficit hyperactivity disorder (ADHD) and bipolar disease. Moreover, pharmaceutical companies across the world are investing and engaging in strategic partnerships to extend their product portfolio and market reach. They are also emphasizing on offering patients with information concerning various conditions and following treatments as well as organizing, tracking, and self-managing their diseases. These initiatives undertaken by pharmaceutical companies are projected to impel the growth of the market.
The global Digital Therapeutics (DTx) market is segregated on the basis of Application as Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation and Others. Based on End-use, the global Digital Therapeutics (DTx) market is segmented in Patients, Providers, Payers, Employers and Others.
The global Digital Therapeutics (DTx) market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Digital Therapeutics (DTx) market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Noom, Livongo Health, Omada Health, WellDoc, Pear Therapeutics, Proteus Digital Health, Propeller Health, Akili Interactive Labs, Better Therapeutics, Happify, Kaia Health, Mango Health and others are among the major players in the global Digital Therapeutics (DTx) market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Digital Therapeutics (DTx) Market has been segmented as below:
Digital Therapeutics (DTx) Market, By Application
Digital Therapeutics (DTx) Market, By End-use
Digital Therapeutics (DTx) Market, By Region
Digital Therapeutics (DTx) Market, By Company
The report covers:
Report Scope:
The global Digital Therapeutics (DTx) market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Digital Therapeutics (DTx) market share. Major industry players with significant revenue share include Noom, Livongo Health, Omada Health, WellDoc, Pear Therapeutics, Proteus Digital Health, Propeller Health, Akili Interactive Labs, Better Therapeutics, Happify, Kaia Health, Mango Health and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Market Research Process
2.3. Research Data Analysis
2.3.1.1. Secondary Research
2.3.1.2. Primary Research
2.3.1.3. Models for Estimation
2.4. Market Size Estimation
2.4.1. Bottom-Up Approach- Segmental Market Analysis
2.4.2. Top-Down Approach- Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. Porter's Five Force Analysis
5. Digital Therapeutics (DTx) Market, By Application
5.1. Introduction
5.2. Diabetes
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.3. Obesity
5.3.1. Market Overview
5.3.2. Market Size and Forecast
5.4. CVD
5.4.1. Market Overview
5.4.2. Market Size and Forecast
5.5. CNS Disease
5.5.1. Market Overview
5.5.2. Market Size and Forecast
5.6. Respiratory Diseases
5.6.1. Market Overview
5.6.2. Market Size and Forecast
5.7. Smoking Cessation
5.7.1. Market Overview
5.7.2. Market Size and Forecast
5.8. Others
5.8.1. Market Overview
5.8.2. Market Size and Forecast
6. Digital Therapeutics (DTx) Market, By End-use
6.1. Introduction
6.2. Patients
6.2.1. Market Overview
6.2.2. Market Size and Forecast
6.3. Providers
6.3.1. Market Overview
6.3.2. Market Size and Forecast
6.4. Payers
6.4.1. Market Overview
6.4.2. Market Size and Forecast
6.5. Employers
6.5.1. Market Overview
6.5.2. Market Size and Forecast
6.6. Others
6.6.1. Market Overview
6.6.2. Market Size and Forecast
7. Digital Therapeutics (DTx) Market, By Geography
7.1. Introduction
7.2. North America
7.2.1. North America Digital Therapeutics (DTx), By Application
7.2.2. North America Digital Therapeutics (DTx), By End-use
7.3. Europe
7.3.1. Europe Digital Therapeutics (DTx), By Application
7.3.2. Europe Digital Therapeutics (DTx), By End-use
7.4. Asia-Pacific
7.4.1. Asia-Pacific Digital Therapeutics (DTx), By Application
7.4.2. Asia-Pacific Digital Therapeutics (DTx), By End-use
7.5. Rest of the World
7.5.1. Rest of the World Digital Therapeutics (DTx), By Application
7.5.2. Rest of the World Digital Therapeutics (DTx), By End-use
8. Competitive Insights
8.1. Key Insights
8.2. Company Market Share Analysis
8.3. Strategic Outlook
8.3.1. Mergers & Acquisitions
8.3.2. New Product Developments
8.3.3. Portfolio/Production Capacity Expansions
8.3.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5. Others
9. Company Profiles
9.1. Noom
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. Livongo Health
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. Omada Health
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. WellDoc
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. Pear Therapeutics
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
9.6. Proteus Digital Health
9.6.1. Company Overview
9.6.2. Product/Service Landscape
9.6.3. Financial Overview
9.6.4. Recent Developments
9.7. Propeller Health
9.7.1. Company Overview
9.7.2. Product/Service Landscape
9.7.3. Financial Overview
9.7.4. Recent Developments
9.8. Akili Interactive Labs
9.8.1. Company Overview
9.8.2. Product/Service Landscape
9.8.3. Financial Overview
9.8.4. Recent Developments
9.9. Better Therapeutics
9.9.1. Company Overview
9.9.2. Product/Service Landscape
9.9.3. Financial Overview
9.9.4. Recent Developments
9.10. Happify
9.10.1. Company Overview
9.10.2. Product/Service Landscape
9.10.3. Financial Overview
9.10.4. Recent Developments
9.11. Kaia Health
9.11.1. Company Overview
9.11.2. Product/Service Landscape
9.11.3. Financial Overview
9.11.4. Recent Developments
9.12. Mango Health
9.12.1. Company Overview
9.12.2. Product/Service Landscape
9.12.3. Financial Overview
9.12.4. Recent Developments
9.13. Click Therapeutics
9.13.1. Company Overview
9.13.2. Product/Service Landscape
9.13.3. Financial Overview
9.13.4. Recent Developments
9.14. Canary Health
9.14.1. Company Overview
9.14.2. Product/Service Landscape
9.14.3. Financial Overview
9.14.4. Recent Developments
9.15. Wellthy Therapeutics
9.15.1. Company Overview
9.15.2. Product/Service Landscape
9.15.3. Financial Overview
9.15.4. Recent Developments
9.16. Cognoa
9.16.1. Company Overview
9.16.2. Product/Service Landscape
9.16.3. Financial Overview
9.16.4. Recent Developments
9.17. Ayogo Health
9.17.1. Company Overview
9.17.2. Product/Service Landscape
9.17.3. Financial Overview
9.17.4. Recent Developments
9.18. Mindstrong Health
9.18.1. Company Overview
9.18.2. Product/Service Landscape
9.18.3. Financial Overview
9.18.4. Recent Developments
9.19. 2Morrow
9.19.1. Company Overview
9.19.2. Product/Service Landscape
9.19.3. Financial Overview
9.19.4. Recent Developments
9.20. Ginger
9.20.1. Company Overview
9.20.2. Product/Service Landscape
9.20.3. Financial Overview
9.20.4. Recent Developments
The Digital Therapeutics (DTx) Market has been segmented as below:
Digital Therapeutics (DTx) Market, By Application
Digital Therapeutics (DTx) Market, By End-use
Digital Therapeutics (DTx) Market, By Region
Digital Therapeutics (DTx) Market, By Company
Got a question? We've got answers. If you have some other questions, see our support center.
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE